Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Endocrinology

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO.141.5.7461PMID 10803592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2.

  1998cited by this paper
• Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration

  1998cited by this paper
• Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector

  1997cited by this paper
• Use of manganese in RT-PCR eliminates PCR artifacts resulting from DNase I digestion.

  1997cited by this paper
• Oct-1, silencer sequence, and GC box regulate thyroid hormone receptor β1 promoter

  1997cited by this paper
• The function of retinoid X receptors on negative thyroid hormone response elements.

  1997cited by this paper
• The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer.

  1997cited by this paper
• Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.

  1996cited by this paper
• An intron enhancer recognized by splicing factors activates polyadenylation.

  1996cited by this paper
• Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma

  1996cited by this paper
• Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models

  1996cited by this paper
• Gene therapy for α‐fetoprotein‐producing human hepatoma cells by adenovirus‐mediated transfer of the herpes simplex virus thymidine kinase gene

  1996cited by this paper
• Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus‐mediated gene transfer of herpes simplex virus thymidine kinase

  1995cited by this paper
• An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene

  1995cited by this paper
• Cooperation of 5' and 3' processing sites as well as intron and exon sequences in calcitonin exon recognition.

  1995cited by this paper
• Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.

  1995cited by this paper
• Medullary Thyroid Carcinoma: Recent Advances and Management Update

  1995cited by this paper
• Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.

  1995cited by this paper
• Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.

  1995cited by this paper
• Treatment of Experimental Human Mesothelioma Using Adenovirus Transfer of the Herpes Simplex Thymidine Kinase Gene

  1995cited by this paper
• Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element

  1995cited by this paper
• Adenovirus‐mediated gene therapy of experimental gliomas

  1994cited by this paper
• The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing.

  1994cited by this paper
• Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

  1994cited by this paper
• Gene transfer technologies for the gene therapy of cancer.

  1994cited by this paper
• The exon 4 poly(A) site of the human calcitonin/CGRP-I pre-mRNA is a weak site in vitro.

  1994cited by this paper
• Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA

  1994cited by this paper
• Calcitonin gene expression in normal human liver

  1993cited by this paper
• Regulation of tissue-specific splicing of the calcitonin/calcitonin gene-related peptide gene by RNA-binding proteins.

  1993cited by this paper
• The basic science of gene therapy.

  1993cited by this paper
• A distal region of the CALC‐1 gene is necessary for regulated alternative splicing

  1993cited by this paper
• Cell-specific glucocorticoid repression of calcitonin/calcitonin gene-related peptide transcription. Localization to an 18-base pair basal enhancer element.

  1992cited by this paper
• A tissue-specific small nuclear ribonucleoprotein and the regulated splicing of the calcitonin/calcitonin gene-related protein transcript.

  1992cited by this paper
• Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements.

  1990cited by this paper
• Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma

  1990cited by this paper
• Calcitonin exon sequences influence alternative RNA processing.

  1990cited by this paper
• Transfection of calcitonin gene regulatory elements into a cell culture model of the C cell

  1990cited by this paper
• Transcriptional regulation of the human calcitonin gene: a progress report.

  1989cited by this paper
• Model for tissue specific Calcitonin/CGRP-I RNA processing from in vitro experiments.

  1988cited by this paper
• Differential regulation of the coexpressed calcitonin/alpha-CGRP and beta-CGRP neuroendocrine genes.

  1988cited by this paper
• Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene.

  1987cited by this paper
• Splice commitment dictates neuron-specific alternative RNA processing in calcitonin/CGRP gene expression.

  1987cited by this paper
• Structure and expression of the human calcitonin/CGRP genes

  1986cited by this paper
• Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

  1986cited by this paper
• Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

  1986cited by this paper
• Regulation of neuroendocrine gene expression by alternative RNA processing. Colocalization of calcitonin and calcitonin gene-related peptide in thyroid C-cells.

  1985cited by this paper
• Calcitonin gene-related peptide in the human thyroid, pituitary and brain.

  1984cited by this paper
• Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

  1983cited by this paper
• Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products

  1982cited by this paper
• Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1.

  1981cited by this paper
• Calcitonin in extrathyroidal tissues of man.

  1979cited by this paper

• Apoptosis is induced by shikonin through the mitochondrial signaling pathway.

  2016cites this paper
• Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm

  2014cites this paper
• Baculovirus Vector-Mediated Transfer of Sodium Iodide Symporter and Plasminogen Kringle 5 Genes for Tumor Radioiodide Therapy

  2014cites this paper
• Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas

  2012cites this paper
• Gene Therapy in Thyroid Cancer

  2009cites this paper
• Technology Insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma

  2007cites this paper
• Le carcinome médullaire de la thyroïde : les nouvelles approches thérapeutiques

  2007cites this paper
• Recent advances in treatment of medullary thyroid carcinoma.

  2007cites this paper
• Gene therapy for thyroid cancer

  2006cites this paper
• Transcriptionally targeted adenovirus vectors.

  2005cites this paper
• A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.

  2005cites this paper
• Gene therapy for thyroid cancer STRATEGIES USED FOR THYROID CANCER GENE THERAPY Silencing of oncogenes

  2005cites this paper
• Gene therapy for thyroid cancer

  2004cites this paper
• Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma

  2004cites this paper
• Gene Therapy for Thyroid Cancer: Current Status and Future Prospects

  2004cites this paper
• Endocrine aspects of cancer gene therapy.

  2004cites this paper
• Dendritic Cell Vaccination in Medullary Thyroid Carcinoma

  2004cites this paper
• Gene therapy for thyroid cancer.

  2004cites this paper
• Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells.

  2003cites this paper
• Antitumor Capacity of a Dominant-Negative RET Proto-Oncogene Mutant in a Medullary Thyroid Carcinoma Model

  2003cites this paper
• Transcriptional Targeting in Cancer Gene Therapy

  2003cites this paper
• Gentherapeutische Intervention beim medullären Schilddrüsenkarzinom durch adenoviral vermittelte Expression dominant-negativer RET Proto-Onkogen Mutanten

  2003cites this paper
• Gene therapeutic approaches for medullary thyroid carcinoma treatment

  2003cites this paper
• Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells.

  2002cites this paper
• Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12

  2002cites this paper
• Cell-Specific Cre-Mediated Activation of the Diphtheria Toxin Gene in Pituitary Tumor Cells: Potential for Cytotoxic Gene Therapy

  2002cites this paper
• Cancer médullaire de la thyroïde

  2001cites this paper
• Induction of a cellular and humoral immune response against preprocalcitonin by genetic i: a potential new treatment for medullary thyroid carcinoma.

  2001cites this paper
• Induction of a Cellular and Humoral Immune Response against Preprocalcitonin by Genetic Immunization: A Potential New Treatment for Medullary Thyroid Carcinoma.

  2001cites this paper
• Gene therapy of brain and endocrine tumors.

  2001cites this paper